(Q36589297)

15 August 2017

1 reference

title

Antifungal efficacy and pharmacodynamics of posaconazole in experimental models of invasive fungal infections (English)

1 reference

invasive fungal infections

15 August 2017

main subject

1 reference

1 reference

2

Thomas J Walsh

1 reference

15 August 2017

Andreas H Groll

1

1 reference

15 August 2017

publication date

1 January 2006

1 reference

15 August 2017

1 reference

15 August 2017

volume

49 Suppl 1

1 reference

15 August 2017

page(s)

7-16

1 reference

Posaconazole: clinical pharmacology and potential for management of fungal infections

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Posaconazole as salvage therapy for zygomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Pharmacokinetics of SCH 56592, a new azole broad-spectrum antifungal agent, in mice, rats, rabbits, dogs, and cynomolgus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Antifungal activity and pharmacokinetics of posaconazole (SCH 56592) in treatment and prevention of experimental invasive pulmonary aspergillosis: correlation with galactomannan antigenemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Interactions of posaconazole and flucytosine against Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

SCH56592 treatment of murine invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Efficacy of SCH56592 in a rabbit model of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Efficacy of posaconazole in a murine model of central nervous system aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Activity of posaconazole combined with amphotericin B against Aspergillus flavus infection in mice: comparative studies in two laboratories

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Experimental pulmonary aspergillosis due to Aspergillus terreus: pathogenesis and treatment of an emerging fungal pathogen resistant to amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Antifungal therapy of murine Aspergillus terreus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Effect of granulocyte colony-stimulating factor combination therapy on efficacy of posaconazole (SCH56592) in an inhalation model of murine pulmonary aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Activity of posaconazole against Pseudallescheria boydii: in vitro and in vivo assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Antifungal activities of posaconazole and granulocyte-macrophage colony-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Posaconazole therapy of disseminated phaeohyphomycosis in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Antifungal therapy of experimental cerebral phaeohyphomycosis due to Cladophialophora bantiana

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei")

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Activity of posaconazole in treatment of experimental disseminated zygomycosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

In vitro and in vivo activities of posaconazole against Coccidioides immitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

Pharmacodynamics of a new triazole, posaconazole, in a murine model of disseminated candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1439-0507.2006.01296.X

10.1111/J.1439-0507.2006.01296.X

21 January 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference